1 |
Isona MG,Hager J,Blumberg, E,et al. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee[J]. Am J Transplant, 2009, 9(8): 1929-1935.
|
2 |
Fishman JA. Infection in solid-organ transplant recipients[J]. N Engl J Med, 2007, 357(25): 2601-2614.
|
3 |
Cai CJ,Lu MQ,Li MR, et al. The distribution and pathogen of bacteria infection in patients after liver transplantation[J]. Zhong-hua Wai Ke Za Zhi, 2006, 44(15):1026-1028.
|
4 |
Romero FA,Razonable RR. Infections in liver transplant recipi-ents[J]. World J Hepatol, 2011, 3(4): 83-92.
|
5 |
Vera A,Contreras F,Guevara F. Incidence and risk factors for in-fections after liver transplant: single-center experience at the University Hospital Fundación Santa Fe de Bogotá, Colombia[J]. Transpl Infect Dis, 2011, 13(6): 608-615.
|
6 |
Li C,Wen TF,Mi K, et al. Analysis of infections in the first 3-month after living donor liver transplantation[J]. World J Gastro-enterol, 2012, 18(16): 1975-1980.
|
7 |
Bonatti H,Pruett TL,Brandacher G, et al. Pneumonia in solid or-gan recipients: spectrum of pathogens in 217 episodes[J]. Trans-plant Proc, 2009, 41(1): 371-374.
|
8 |
Pugliese F,Ruberto F,Cappannoli A, et al. Incidence of fungal infections in a solid organ recipients dedicated intensive care unit[J]. Transplant Proc, 2007, 39(6): 2005-2007.
|
9 |
Wolach B,Sazbon L,Gavrieli R, et al. Early immunological de-fects in comatose patients after acute brain injury[J]. J Neurosurg, 2001, 94(5): 706-711.
|
10 |
Griffin GD. The injured brain: TBI, mTBI, the immune system, and infection: connecting the dots[J]. Mil Med, 2011, 176(4): 364-368.
|
11 |
Cerutti E,Stratta C,Romagnoli R, et al. Bacterial-and fungal-positive cultures in organ donors: clinical impact in liver trans-plantation[J]. Liver Transpl, 2006, 12(8): 1253-1259.
|
12 |
Avery RK. Prophylactic strategies before solid-organ transplanta-tion[J]. Curr Opin Infect Dis, 2004, 17(4): 353-356.
|
13 |
Gao B,Jeong WI,Tian Z. Liver: an organ with predominant in-nate immunity[J]. Hepatology, 2008, 47(2): 729-736.
|
14 |
Hosein S,Udy AA,Lipman J. Physiological changes in the criti-cally ill patient with sepsis[J]. Curr Pharma Biotech, 2011, 12(12): 1991-1995.
|